BIOMAT Database Logo BIOMAT Database Logo

Pth 1-84, Pth fragments and bone turnover. 2003

Hartmut H Malluche, and Marie-Claude Monier-Faugere

UI MeSH Term Description Entries
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016723 Bone Remodeling The continuous turnover of BONE MATRIX and mineral that involves first an increase in BONE RESORPTION (osteoclastic activity) and later, reactive BONE FORMATION (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium HOMEOSTASIS. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS. Bone Turnover,Bone Turnovers,Remodeling, Bone,Turnover, Bone,Turnovers, Bone

Related Publications

Hartmut H Malluche, and Marie-Claude Monier-Faugere
7-84 PTH lowers bone turnover and explains why the 1-84 PTH/7-84 PTH ratio predicts bone turnover.
July 2004, Kidney international,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
[Whole PTH and 1-84/84 PTH ratio for the non invasive determination of low bone turnover in renal osteodysthrophy].
January 2003, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.
August 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
PTH(1-84)/PTH(7-84): a balance of power.
May 2006, American journal of physiology. Renal physiology,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
The value of the (1-84) PTH/C-PTH ratio for the diagnosis of low bone turnover in dialysis patients.
March 2002, Kidney international,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
Atrophic femoral bone nonunion treated with 1-84 PTH.
December 2011, Journal of musculoskeletal & neuronal interactions,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
May 2006, Clinical nephrology,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries.
May 2016, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.
January 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Hartmut H Malluche, and Marie-Claude Monier-Faugere
The opposing actions of the two parathyroid hormones, 1-84 PTH and 7-84 PTH: improvement in renal bone and calcium metabolism management.
October 2004, Hemodialysis international. International Symposium on Home Hemodialysis,
Copied contents to your clipboard!